Industry News
Kids Need To Use More Sunscreen
Jan 23, 2012
A study published in the journal Pediatrics shows that most pre-adolescent children do not regularly use sunscreen, and worse, many suffer from sunburn at some point during their childhood... Read More
Kids Need To Use More Sunscreen
Jan 23, 2012
A study published in the journal Pediatrics shows that most pre-adolescent children do not regularly use sunscreen, and worse, many suffer from sunburn at some point during their childhood... Read More
Colon Cancer Survival Improved With Use Of Oxaliplatin
Jan 23, 2012
In 2011, about 101,340 Americans have been diagnosed with colon cancer, a leading worldwide cause of both illness and death, with around one third of cancers being diagnosed as stage III, or node-positive disease... Read More
Lower Quality Of Life In Young Women With Breast Cancer
Jan 23, 2012
A study in the Journal of the National Cancer Institute reveals that health-related quality of life (QOL) is lower in younger women with breast cancer. This decrease is linked to weight gain, increased psychological distress, less physical activity and early onset menopause, as well as infertility. In the U.S... Read More
Statins May Work Against Certain Breast Cancers
Jan 23, 2012
Statins are commonly prescribed to lower cholesterol, but a recent study suggest certain types of breast cancer may respond to treatment with statins... Read More
A Cause Of Resistance To Colon Cancer Treatment Identified
Jan 23, 2012
Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR... Read More
Colon Cancer Patient Survival Improved By Oxaliplatin
Jan 23, 2012
Stage III colon cancer patients in the general population who receive adjuvant treatment for the disease have an improved rate of survival when oxaliplatin is added to 5-fluorouracil (5FU), according to a study published in the Journal of the National Cancer Institute. Colon cancer is a leading global cause of both illness and death; with an estimated 101,340 cases among Americans in 2011... Read More
Researchers Refine Nanoparticles For More Accurate Delivery Of Cancer Drugs
Jan 23, 2012
A new class of nanoparticles, synthesized by a UC Davis research team to prevent premature drug release, holds promise for greater accuracy and effectiveness in delivering cancer drugs to tumors. The work is published in the current issue of Angewandte Chemie, a leading international chemistry journal... Read More
Mechanism Of Lung-Cancer Drug Resistance Revealed By Study
Jan 23, 2012
New research published in Nature Medicine indicates that targeted drugs such as gefitinib might more effectively treat non-small cell lung cancer if they could be combined with agents that block certain microRNAs. The study was led by investigators with the Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J... Read More
By Stifling Protective Genes, Inflammatory Mediator Promotes Colorectal Cancer
Jan 23, 2012
Chronic inflammation combines with DNA methylation, a process that shuts down cancer-fighting genes, to promote development of colorectal cancer, scientists at The University of Texas MD Anderson Cancer Center report today in the advance online publication of the journal Nature Medicine... Read More
Previous Page Next Page